Endoluminal treatment of infrarenal aortic aneurysms: Clinical experience with the talent stent-graft system

Citation
Ka. Hausegger et al., Endoluminal treatment of infrarenal aortic aneurysms: Clinical experience with the talent stent-graft system, J VAS INT R, 10(3), 1999, pp. 267-274
Citations number
21
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
ISSN journal
10510443 → ACNP
Volume
10
Issue
3
Year of publication
1999
Pages
267 - 274
Database
ISI
SICI code
1051-0443(199903)10:3<267:ETOIAA>2.0.ZU;2-8
Abstract
PURPOSE: To evaluate the safety and efficacy of the Talent stent-graft (TSG ) system in the endoluminal treatment of infrarenal abdominal aortic aneury sms (AAAs), PATIENTS AND METHODS: Endoluminal treatment of an AAA was attempted in 30 m en with a mean age of 70.5 years (range, 51-83 years). Seven patients had A AAs suitable for treatment with a tube graft. In the other patients, treatm ent with a bifurcated TSG: was planned, All procedures were performed as a combined surgical-radiologic procedure in an angiographic room. RESULTS: Primary technical success was achieved in 25 of 30 patients (83%), Technical failures were due to misplacement of the TSG; (n = 2) with proxi mal leakage as a consequence, inability to gain access via the iliac arteri es (n = 1), and a distal leakage (n = 2), Secondary interventions (n = 2) a nd spontaneous thrombosis of a distal leak (n = 1) increased the secondary technical success rate to 93% (28 of 30), Two procedures were converted to open surgery (conversion rate = 6%), One patient died during the first 30 d ays after uncomplicated stent-graft insertion because of myocardial infarct ion (30-day mortality = 5%). No complications occurred during a mean follow -up of 15.4 months (range, 6-19 months), The maximum diameter of the AAA de creased in eight patients and remained unchanged in the remaining patients, No increase in diameter was observed. No late endoleak or migration of the TSG was observed. CONCLUSION: The TSG-system revealed satisfactory initial and early follow-u p results. Treatment of AAAs with this stent-graft system is feasible. The technical success rate in carefully selected patients should be 90% or more , However, long-term observations are necessary to determine if the encoura ging early results of this type of therapy can be preserved during long-ter m follow-up.